StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$39.45−0.57 (-1.42%)

Close on Nov 18, 2026Market cap $1.84BP/E –Yield –

Septerna operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Septerna's operating income for the twelve months ending Sep 30, 2026 was -$73.39M. For fiscal 2025 it was -$68.30M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$68.30M–
FY2024Dec 31, 2024-$80.82M-3995.1%
FY2023Dec 31, 2023$2.08M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$27.23M-1141.7%
Q2 FY2026Jun 30, 2026-$16.84M–
Q1 FY2026Mar 31, 2026-$13.30M–
Q4 FY2025Dec 31, 2025-$16.02M–
Q3 FY2025Sep 30, 2025$2.61M–
Q2 FY2025Jun 30, 2025-$28.98M–
Q1 FY2025Mar 31, 2025-$25.91M–
Q4 FY2024Dec 31, 2024-$24.72M-172.0%
Q3 FY2024Sep 30, 2024-$22.55M–
Q2 FY2024Jun 30, 2024-$18.07M–
Q1 FY2024Mar 31, 2024-$15.49M–
Q4 FY2023Dec 31, 2023$34.32M–
Q3 FY2023Sep 30, 2023-$12.04M–

More Septerna figures

See a number that looks wrong?